HCA Healthcare (HCA)

The sleeper story is that HCA's 2027 'generally consistent with 2026' earnings guide is leaning on a Medicaid supplemental payment cliff that management has now explicitly quantified at $550-650 million, funded this year by one-time, out-of-period catch-up payments they raised guidance on specifically because they won't repeat. The obvious headline, accelerating volume growth (3% equivalent admissions, 22nd straight quarter), is real but masks the fact that exchange volumes came in worse than their own internal forecast (19% decline vs. 15-16% expected) and the binding constraint on 2027 visibility is entirely external: open enrollment data they won't have until mid-January. The most telling moment was Mike Marks's answer when pressed to quantify 2027 resiliency savings: 'resiliency is just part of our core operations', a non-answer to the exact question that determines whether the earnings gap gets filled. My view changes if January guidance actually attaches a specific EBITDA or EPS range to 2027 rather than more 'generally consistent' language, or if Q4 exchange volumes stabilize meaningfully above the sequential pattern they're quietly hoping repeats from last year's easier comp.